Despite still being alterable by “classical” IFN or NFκB signaling, our findings indicate upregulation of IFIT3 without an adequate inflammatory stimulus in the more aggressive pancreatic cancer cell line. The gene discussed is IFIT3; the disease is familial pancreatic carcinoma.